Press release
KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the appointments of Bilal Arif as
About this update from Kalvista Pharmaceuticals, Inc.
[{"type":"text","content":" FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--\nKalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025.\n\n\n“I am pleased to welcome Bilal and Linea to our leadership team as we advance the global launch of EKTERLY,” said Ben Palleiko, Chief Executive Officer of KalVista. “Their respective expertise in operations and human resources will be instrumental as we deliver on our commitment to people living with HAE.”\n\n\n“I am excited to join KalVista and collaborate with such a talented team,” said Mr. Arif. “This is a pivotal time for EKTERLY, and I am focused on strengthening the operational framework to ensure people living with HAE fully benefit from this innovative therapy.”\n\n\n“I am delighted to join KalVista at this important stage of the Company’s growth,” said Ms. Aspesi. “As EKTERLY expands globally, I am committed to shaping the people and organizational strategies that will support the business in achieving its ambitious goals.”\n\n\nBilal Arif is a senior biopharmaceutical operations executive with more than 25 years of experience spanning technical operations, product strategy, and manufacturing in both emerging biotech and global pharmaceutical organizations, supporting multiple global launches. He most recently served as Executive Vice President and Chief Technical Operations Officer at Sarepta Therapeutics, where he also held the role of Senior Vice President, Strategy and Technical Operations. Before joining Sarepta, Mr. Arif was Vice President of Technical Operations at Momenta Pharmaceuticals. Earlier in his career, he spent nearly a decade at Shire Pharmaceuticals, serving in senior leadership positions, including Vice President of Product Strategy and Planning, Technical Operations, and Senior Director of the External Manufacturing Group. Mr. Arif also held leadership roles in contract manufacturing at Altus Pharmaceuticals and began his career as a chemical engineer at Millipore Corporation.\n\n\nMr. Arif holds an MBA from Brown University / IE Business School, an M.S. in Biotechnology from Tufts University, and a B.Eng. in Chemical Engineering from McGill University in Canada.\n\n\nLinea Aspesi is a seasoned human resources executive with more than 25 years of le...